EG18088A - Method for production of stable nicorantil preparation - Google Patents

Method for production of stable nicorantil preparation

Info

Publication number
EG18088A
EG18088A EG19/87A EG1987A EG18088A EG 18088 A EG18088 A EG 18088A EG 19/87 A EG19/87 A EG 19/87A EG 1987 A EG1987 A EG 1987A EG 18088 A EG18088 A EG 18088A
Authority
EG
Egypt
Prior art keywords
nicorantil
stable
preparation
production
stable nicorantil
Prior art date
Application number
EG19/87A
Other languages
English (en)
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26342067&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG18088(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of EG18088A publication Critical patent/EG18088A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG19/87A 1986-01-17 1987-01-13 Method for production of stable nicorantil preparation EG18088A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP772286 1986-01-17
JP6185686 1986-03-19

Publications (1)

Publication Number Publication Date
EG18088A true EG18088A (en) 1992-08-30

Family

ID=26342067

Family Applications (1)

Application Number Title Priority Date Filing Date
EG19/87A EG18088A (en) 1986-01-17 1987-01-13 Method for production of stable nicorantil preparation

Country Status (21)

Country Link
US (1) US4822808A (no)
EP (1) EP0230932B1 (no)
KR (1) KR940000232B1 (no)
CN (1) CN1009525B (no)
AR (1) AR241514A1 (no)
AU (1) AU591958B2 (no)
CA (1) CA1285486C (no)
CS (1) CS276587B6 (no)
DE (1) DE3769662D1 (no)
DK (1) DK174918B1 (no)
EG (1) EG18088A (no)
ES (1) ES2054623T3 (no)
FI (1) FI87043C (no)
GR (1) GR3002288T3 (no)
HK (1) HK66193A (no)
HU (1) HU196705B (no)
MX (1) MX167912B (no)
NO (1) NO173590C (no)
NZ (1) NZ218917A (no)
PT (1) PT84124B (no)
SG (1) SG64893G (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637322A (en) * 1992-11-06 1997-06-10 Japan Tobacco Inc. Method for producing composition for solid medicine
US6218411B1 (en) * 1997-08-08 2001-04-17 Chugai Seiyaku Kabushiki Kaisha Therapeutics for diabetic complications
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
JP5048177B2 (ja) * 1998-05-15 2012-10-17 中外製薬株式会社 放出制御製剤
WO2000067754A1 (en) 1999-05-12 2000-11-16 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
FR2872705B1 (fr) * 2004-07-08 2008-07-18 Aventis Pharma Sa Compositions contenant du nicorandil, procede de preparation et utilisation
WO2008112227A1 (en) * 2007-03-12 2008-09-18 Reliant Pharmaceuticals, Inc. Treatment with nicorandil and omega-3 fatty acids, and a combination product thereof
SI2098249T1 (sl) * 2008-03-05 2013-02-28 Rivopharm Sa Nosilci nikorandila s povečano stabilnostjo
KR20100007082A (ko) * 2008-07-11 2010-01-22 주식회사 엘지생명과학 니코란딜을 포함하는 서방성 제제
JPWO2010018866A1 (ja) * 2008-08-14 2012-01-26 杏林製薬株式会社 安定化された医薬組成物
WO2014174846A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物
CN110123749B (zh) * 2019-06-03 2022-01-25 太阳升(亳州)生物医药科技有限公司 尼可地尔脂微球制剂及其制备方法
CN111574441B (zh) * 2020-05-26 2021-12-31 中国科学院上海药物研究所 一种尼可地尔与水杨酸的共晶及其制备方法和应用
CN115429763B (zh) * 2021-06-02 2024-01-02 北京四环科宝制药股份有限公司 尼可地尔片剂及其制备方法
CN114732792A (zh) * 2022-03-25 2022-07-12 北京诺康达医药科技股份有限公司 一种尼可地尔口腔崩解片及其制备方法
CN115317456A (zh) * 2022-08-17 2022-11-11 北京科源创欣科技有限公司 一种尼可地尔片组合物及其制备方法
CN115282123B (zh) * 2022-09-13 2023-11-03 南京比逊医药科技有限公司 一种稳定的尼可地尔制剂的制备方法
CN117547534B (zh) * 2023-11-10 2024-07-12 江南大学 尼可地尔缓释制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168438A (en) * 1962-08-09 1965-02-02 Synergistics Inc Vasodilation by nitric acid ester derivatives of nicotinic acid
US3332848A (en) * 1963-07-10 1967-07-25 Hoffmann La Roche Microcrystalline cellulose with starch in niacinamide ascorbic acid tablet granulations
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
US4490377A (en) * 1980-07-29 1984-12-25 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
JPS57145659A (en) * 1981-03-06 1982-09-08 Chugai Pharmaceutical Co Ltd Production of tablet
US4382091A (en) * 1981-04-30 1983-05-03 Syntex (U.S.A.) Inc. Stabilization of 1-substituted imidazole derivatives in talc
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent

Also Published As

Publication number Publication date
NZ218917A (en) 1989-10-27
HUT44435A (en) 1988-03-28
EP0230932B1 (en) 1991-05-02
MX167912B (es) 1993-04-22
NO870212D0 (no) 1987-01-19
AU6764887A (en) 1987-07-23
SG64893G (en) 1993-08-06
KR870006894A (ko) 1987-08-13
EP0230932A2 (en) 1987-08-05
ES2054623T3 (es) 1994-08-16
NO173590B (no) 1993-09-27
FI870131A (fi) 1987-07-18
KR940000232B1 (ko) 1994-01-12
GR3002288T3 (en) 1992-12-30
DK174918B1 (da) 2004-02-23
PT84124B (pt) 1989-02-28
FI87043C (fi) 1992-11-25
HU196705B (en) 1989-01-30
CN1009525B (zh) 1990-09-12
PT84124A (en) 1987-02-01
CN87100285A (zh) 1987-08-19
US4822808A (en) 1989-04-18
CS276587B6 (en) 1992-07-15
FI870131A0 (fi) 1987-01-14
NO870212L (no) 1987-07-20
FI87043B (fi) 1992-08-14
EP0230932A3 (en) 1987-12-09
CS8700282A2 (en) 1991-07-16
AU591958B2 (en) 1989-12-21
DK19187A (da) 1987-07-18
AR241514A1 (es) 1992-08-31
HK66193A (en) 1993-07-16
DK19187D0 (da) 1987-01-15
NO173590C (no) 1994-01-05
CA1285486C (en) 1991-07-02
DE3769662D1 (de) 1991-06-06

Similar Documents

Publication Publication Date Title
HUT45193A (en) Process for production of galenicum
ZA859390B (en) Method for production of stable nicorandil preparation
EG18088A (en) Method for production of stable nicorantil preparation
YU181285A (en) Process for preparation of sylibinine without izosylibinine
HU896623D0 (en) Process for preparation of fluorinated-diphenyl-ethers
ZA87279B (en) Method for production of stable nicorandil preparation
HUT44475A (en) Process for production of chlor-carbonic-acid-chlorids
CS597887A2 (en) Method of new lensofuran-2 ylimidazol derivatives production
ZA879331B (en) Method for preparation of mercaptobenzoates
EP0249969A3 (en) Process for production of 1-aminoauthraquinone
HU895128D0 (en) Process for preparation of oxazolidine- and imidazolidine-derivatives
CS186887A2 (en) Method of alkylsuphonyl-alkylchlorobenzenes preparation
GB2190373B (en) Method of preparing bromobenzotrifluoride
HU896622D0 (en) Process for preparation of 3-benzyl-4-fluor-benzaldehyde
CS850787A2 (en) Method of substituted 1-phenoxy-3-amino-2-propanols production
HUT44017A (en) Process for production of 3-hydroxi-methil-izokynolins
CS292087A2 (en) Method of ergolen derivatives production
AR243500A1 (es) Procedimiento para preparar compuestos de mercaptobenzoato.
BG49938A3 (en) Method for preparing of anilinefumarate
HUT48562A (en) Process for production of substituated fluor-benzols
GB8729133D0 (en) Method for production of 1-valine
CS686987A2 (en) Method of new 1-aryloxy-dihydrobenzothiadiazinyl alkylamino-alkanes production
CS105389A2 (en) Method of 4-benzyloxy-3-pyrroline-2-on-1-yl-acetamide production
CS548787A2 (en) Method of new tetrahydrobenzothiazolo-quinolines production
CS821986A1 (en) Method of preparation of chestnut-extract